Stilley William B. III 4
4 · ADIAL PHARMACEUTICALS, INC. · Filed Mar 27, 2020
Insider Transaction Report
Form 4
Stilley William B. III
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2020-03-25$1.13/sh+12,348$13,953→ 703,285 total - Purchase
Common Stock
2020-03-26$1.47/sh+12,652$18,598→ 715,937 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These 12,348 shares of common stock were purchased in multiple transactions at prices ranging from $1.08 to $1.2708, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4
- [F2]The price reported in Column 4 is a weighted average price. These 12,652 shares of common stock were purchased in multiple transactions at prices ranging from $1.4350 to $1.50, inclusive. The reporting person undertakes to provide to Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.